Rifampicin and Isoniazid (FUNFUNATI-1) Manufacturer, Supplier in Vapi, Gujarat
Rifampicin 300mg and Isoniazid 150mg Tablets Manufacturer in India
Trusted Manufacturer of Rifampicin 300mg and Isoniazid 150mg Tablets
We are a globally recognized manufacturer, exporter, and supplier of Rifampicin 300mg and Isoniazid 150mg Tablets, delivering high-quality anti-tuberculosis formulations that meet international standards. Our manufacturing facilities are equipped with advanced technology and operate under stringent quality control systems to ensure consistent product excellence.
Our fixed-dose combination of Rifampicin and Isoniazid is widely used in the effective treatment of tuberculosis (TB), helping healthcare providers improve patient compliance and therapeutic outcomes. With a strong presence across India and international markets including Africa, the Middle East, and Latin America, we have established ourselves as a reliable pharmaceutical partner.
Comprehensive Overview of Rifampicin and Isoniazid Tablets
Rifampicin 300mg and Isoniazid 150mg Tablets are a powerful combination therapy designed to combat Mycobacterium tuberculosis, the bacteria responsible for tuberculosis. This formulation is recommended as part of first-line anti-TB treatment protocols.
Composition
- Rifampicin 300mg
- Isoniazid 150mg
Dosage Form
- Oral Tablets
Therapeutic Category
- Anti-tuberculosis (Anti-TB) Medication
Mechanism of Action
This dual-drug combination works synergistically to eliminate tuberculosis-causing bacteria:
- Rifampicin inhibits bacterial RNA synthesis by targeting DNA-dependent RNA polymerase, effectively stopping bacterial replication.
- Isoniazid interferes with the synthesis of mycolic acids, essential components of the bacterial cell wall, thereby destroying the protective barrier of TB bacteria.
Together, these mechanisms ensure rapid bacterial eradication and prevent the development of drug resistance when taken as prescribed.
Indications and Usage
We manufacture Rifampicin and Isoniazid Tablets primarily for:
- Treatment of active tuberculosis (pulmonary and extrapulmonary TB)
- Use in combination therapy as per WHO-recommended TB regimens
- Prevention of TB in high-risk individuals (as directed by healthcare professionals)
This fixed-dose combination enhances patient adherence by reducing pill burden and simplifying treatment regimens.
Key Benefits of Our Rifampicin and Isoniazid Tablets
1. Improved Patient Compliance
Combining two essential anti-TB drugs into a single tablet reduces the number of medications patients need to take daily.
2. High Therapeutic Efficacy
Our formulation ensures optimal drug bioavailability, leading to effective bacterial clearance.
3. WHO-GMP Certified Manufacturing
We adhere to strict Good Manufacturing Practices (GMP) to guarantee product safety, efficacy, and consistency.
4. Global Export Standards
Our products comply with international regulatory requirements, making them suitable for export to regulated and semi-regulated markets.
Manufacturing Excellence and Quality Assurance
We maintain the highest standards in pharmaceutical manufacturing:
- State-of-the-art production facilities in India
- Stringent quality control at every stage
- Compliance with WHO-GMP, ISO, and other international certifications
- Batch-to-batch consistency and stability testing
Every tablet undergoes rigorous testing to ensure it meets pharmacopoeial specifications before reaching the market.
Dosage and Administration Guidelines
Rifampicin and Isoniazid Tablets should be taken strictly under medical supervision.
- Typically administered once daily on an empty stomach
- Should be taken at least 30 minutes before meals or 2 hours after meals
- Dosage duration depends on the severity and type of tuberculosis
Patients are advised to complete the full course of treatment to prevent relapse and drug resistance.
Side Effects and Safety Profile
While generally well tolerated, some patients may experience mild to moderate side effects:
Common Side Effects
- Nausea and vomiting
- Abdominal discomfort
- Skin rash and itching
- Dizziness and fatigue
Serious but Rare Side Effects
- Hepatitis (liver inflammation)
- Peripheral neuropathy (tingling or numbness in hands and feet)
- Low platelet count
Notable Effect
- Harmless orange-red discoloration of urine, sweat, and tears due to Rifampicin
Regular monitoring of liver function is recommended during prolonged therapy.
Precautions and Warnings
- Avoid alcohol consumption during treatment due to increased risk of liver toxicity
- Patients with pre-existing liver conditions should use with caution
- Vitamin B6 supplementation may be recommended to prevent neuropathy
- Rifampicin may reduce the effectiveness of hormonal contraceptives; alternative methods should be used
Global Supply and Export Network
We are a leading exporter of Rifampicin 300mg and Isoniazid 150mg Tablets, serving a wide range of international markets:
- Africa
- Middle East
- Latin America (LATAM)
- Asia-Pacific regions
Our robust logistics and supply chain management ensure timely delivery and consistent availability of products worldwide.
PCD Pharma Franchise and Business Opportunities
We offer lucrative opportunities for distributors and partners through our PCD Pharma Franchise model:
- Monopoly rights for selected regions
- Comprehensive marketing and promotional support
- Competitive pricing and high-margin products
- Reliable supply chain and timely dispatch
Our franchise model is designed to help partners grow their pharmaceutical business with a trusted brand.
Why Choose Us as Your Manufacturer and Supplier
We stand out as a preferred partner for Rifampicin and Isoniazid Tablets due to:
- Proven track record in pharmaceutical manufacturing
- Commitment to quality and regulatory compliance
- Competitive pricing with premium quality
- Strong global distribution network
- Dedicated customer support and technical assistance
Our focus remains on delivering safe, effective, and affordable medicines to improve global healthcare outcomes.
Packaging and Availability
We offer flexible packaging options to meet diverse market requirements:
- Blister packs
- Alu-Alu packaging
- Bulk packaging for institutional supply
Customized labeling and branding options are available for export clients and franchise partners.
Future Outlook and Commitment
We continue to invest in research, development, and innovation to enhance our product portfolio and address global healthcare challenges. Our commitment to quality, affordability, and accessibility drives us to expand our reach and serve more communities worldwide.
As a leading manufacturer and exporter of Rifampicin 300mg and Isoniazid 150mg Tablets in India, we deliver high-quality, reliable, and effective anti-tuberculosis solutions. Our dedication to excellence, global standards, and customer satisfaction positions us as a trusted partner in the fight against tuberculosis.
